Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

Autor: Yahya Büyükaşık, Rıdvan Ali, Mehmet Turgut, Güray Saydam, Akif Selim Yavuz, Ali Ünal, Muhlis Cem Ar, Orhan Ayyıldız, Fevzi Altuntaş, Müfide Okay, Rafiye Çiftçiler, Özgür Meletli, Nur Soyer, Metban Mastanzade, Zeynep Güven, Teoman Soysal, Abdullah Karakuş, Tuğçe Nur Yiğenoğlu, Barış Uçar, Ece Gökçen, Tülin Tuğlular

Publikováno v: Turkish Journal of Hematology, Vol 37, Iss 3, Pp 177-185 (2020)

Objective: This study aimed to evaluate real-life data on patterns of hydroxyurea prescription/use in polycythemia vera (PV). Materials and Methods: This retrospective chart review study included PV patients who had received hydroxyurea therapy for a

Externí odkaz: https://doaj.org/article/edbc07285c394687a7e423fc25ebb1f5

Shoulder-Pad Sign in a Case of Amyloidosis Associated with Myeloma

Autor: Ceren Uzunoğlu, Tayfur Toptaş, Yıldız İpek, Fatma Arıkan, Fergün Yılmaz, Tülin Tuğlular

Publikováno v: Turkish Journal of Hematology, Vol 38, Iss 3, Pp 233-234 (2021)

Externí odkaz: https://doaj.org/article/dd2ecf54e6e241a3978f248bf0e2b146

MM-174 Retrospective Analysis of a Weekly Carfilzomib-Dexamethasone Regimen in Relapsed/Refractory Multiple Myeloma: Single Center Experience

Autor: Uluköylü, Meral, Gizem Günhan, Hatice, Şişman, İbrahim Talha, Salim, Seçil, Atagündüz, Işık, Fergün Yılmaz, Asu, Toptaş, Tayfur, Arıkan, Fatma, Mert Yanık, Ahmet, Demirtaş, Derya, Candan, Özlem, Tülin Tuğlular, Ayse

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S539-S539

A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia

Autor: Mehmet Sönmez, Sevil Sadri, Vildan Ozkocaman, Hasan Atilla Ozkan, Levent Undar, Ahmet Muzaffer Demir, Olga Meltem Akay Yanar, Derya Selim Bapur, Anil Tombak, Erden Atilla, Volkan Karakuş, Pinar Tarkun, Güray Saydam, Inci Alacacioglu, Can Ozlu, Demet Çekdemir, Hasan Dermenci, Tülin Tuğlular Fıratlı, Demet Aydin, Eyup Naci Tiftik, Müzeyyen Aslaner, Ülkü Ozan, Sehmus Ertop, Ozan Salim, Muhit Ozcan, Tayfur Toptas, Sinan Demircioğlu, Noyan F, Gülsüm Özet, Abdullah Karakuş, Mehmet Ali Özcan, Güven Çetin, Funda Pepedil Tanrikulu, Zafer Gokgoz, Esra Ermiş Turak, Reyhan Diz Küçükkaya, Fusun Ozdemirkiran, Mehmet Turgut, Özkan Sayan, Mesut Ayer, Düzgün Özatlı, Melda Cömert, Neslihan Andic, Mehmet Özen, Pelin Aytan, Mustafa Nuri Yenerel, Oktay Bilgir, Guchan Alanoglu, Ali Ünal, Isik Kaygusuz Atagunduz, Ramazan Esen, Kadir Acar, Alev Akyol Erikçi, Serkan Güvenç, Mustafa Pehlivan, Cenk Sunu, Erman Öztürk, Fadime Ersoy Dursun, Ebru Kızılkılıç, Sinem Namdaroglu, Umit Yavuz Malkan, Burhan Turgut, Nevin Alayvaz, Mustafa Çetiner, Teoman Soysal, Vahap Aslan, Hatice Terzi, Murat Tombuloglu, Ali Eser, Kadriye Bahriye Payzın, Handan Haydaroglu Sahin, Mehmet Gunduz, Mehmet Sinan Dal, Funda Ceran, Orhan Ayyildiz, Emin Kaya, Mehmet Şencan, Ibrahim C. Haznedaroglu, Guven Yilmaz, Burak Deveci, Bahar Uncu Ulu, Ayhan Gulsan Turkoz Sucak, Demet Kiper, Atakan Tekinalp

Publikováno v: Turkish Journal of Hematology.

Objective The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods A total of 285 chronic ITP patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::04c575b6a11e10fc48e69fd4430475c0
https://doi.org/10.4274/tjh.galenos.2019.2018.0307

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.